mr. mclaughlin, appreciate you being on. mr. chamberlain, our condolences on your loss. i'm so sorry.s dig deeper into obligations that the police had to go into the apartment. joining us now is paul callan, former new york city homicide prosecutor, he has extensive experience presenting cases to grand juries. if a life alert has been signaled, are the police under some obligation to make sure he's okay? >> most prosecutors would you tell you this is a gray area, if the police can force their way into the home. we hear about the cassell doctrine, that you need a warrant to enter somebody's home. the police will say they were confronted with a mentally disturbed person who they subsequently find out is armed with a knife and that they had an obligation to enter to make sure he wasn't going to hurt himself. i'm sure that was the claim they probably made in front of the grand jury. >> could there vs also have been a case, had they left, taken his word that he was okay, and it turns out that he had a heart attack or something, they would have been liable or held responsible by his family

mr. mclaughlin? >> i think it's important to recognize that the global -- mobile phone will be one device albeit incredibly compelling device that consumers will use to access their accounts so from a mastercard prospectively want to make sure that all the right protections and privileges consumers have doing that transaction is the same, whether they are using their physical card, whether they are initiating the transaction from a mobile device or shopping on line. that is the reality for our consumers, to be able to trust the transaction and know they are protected wherever they are using it. ably picking sure we aren't creating some separate and independent mobile world but rather seeing these devices as a right and privilege that the people have today is essential. i think it's also important that we allow innovation to flourish in this area and we need to ensure the security and consumer protections. what we can do is constrain or restrict the ability for industry to determine how to create the

mr. president, i also ask unanimous consent that when we turn to h.r. 2072, the export-import bank reauthorization act, that marie mclaughlin, a detailee to the senate finance committee, be granted the privilege of the floor for the duration of consideration of that legislation. the presiding officer: without objection. mr. johanns: thank you, mr. president. mr. president, i rise today with my colleagues to talk about something that i think is an issue that without a solution will affect every single aspect of life in our country, and i'm speaking about our debt crisis, the impending fiscal cliff and the lack of a budget to address those issues. as i said, i'm very pleased to be joined by my colleagues to talk about this issue. unfortunately, for whatever reason, the senate has lacked the will and the leadership to fulfill what i consider its most basic legislative function, writing and adopting a budget resolution. that has gone on for more than three years. while i understand we are rapidly approaching the time where presidential politics will consume the entire agenda, the united states national debt is also rapidly appr

maureen mclaughlin, a detailee from the f.c.c., all be granted the privilege of the floor for the remainder of the second section of the 112th congress. the presiding officer: without objection. mr. hatch: with that, mr. president, i yield the floor and -- i yield the floor. emr. reid: mr. president, i rise today in support of the food and drug administration safety innovation act which is pending before the senate this week. this legislation would give the f.d.a. the resources to approve additional drugs and devices every year for their safe and effective years. without this agreement, the f.d.a. starting in october would lack these resources which are necessary to approve new drugs and devices. and they would also lack resources to montan monitor thes and devices on the market. this would marge nice our drug and device approval. i am pleefs pleased that for the first time the generic pharmaceutical industry will provide the agency with $1.5 billion over five years for faster product reviews. the essence phs legislation is that the industry providing resources for the monitoring and approval of the drugs. getting generic drugs onto the market sooner will help lower costs for in